openPR Logo
Press release

PEGylated Protein Therapeutics Market Outlook 2025: Key Players Amgen, AstraZeneca, Biogen, Horizon Pharma

02-11-2019 11:18 AM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
PEGylated Protein Therapeutics Market Outlook 2025: Key

PEGylation is the process of adding active polyethylene glycol (PEG) to various forms of therapeutic proteins for chemical modification. These chemically modified therapeutic proteins are called pegylated protein therapeutics. Chemical modification due to PEGylation brings about various advantages such as extended half-life of the drug with lower toxicity and increased proteolytic protection than unmodified protein therapy. PEGylated protein therapeutics are used in many conditions such as cancer, hemophilia, rheumatoid arthritis, ankylosing spondylitis, Crohns disease and others.

Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-sample/3726?utm_source=openpr_ss

According to Allied Market Research, the market was valued at $10,388 million in 2017 and is projected to reach $17,813 million by 2025, growing at a CAGR of 6.9% from 2018 to 2025. North America is anticipated to be the highest revenue contributor throughout the forecast period.

Factors driving the growth of the global PEGylated protein therapeutics market are the prevalence of chronic diseases, the benefits of PEGylation and the strong presence of pipeline drugs. However, high costs associated with drug development and generic launches are expected to hamper market growth. In addition, the high market potential in untapped emerging economies and the increased adoption of PEGylated protein therapeutics are expected to provide many opportunities during the forecast period.

By product type, colonial stimuli accounted for nearly half of the worldwide industrial medicines market share in 2017. Also, the cancer portion is expected to grow at a high rate of 7.4% over the forecast period.

Send Enquiry on this Report @ https://www.alliedmarketresearch.com/purchase-enquiry/3726?utm_source=openpr_ss

Major Market Players:

• Amgen Inc.
• AstraZeneca PLC
• Biogen Inc.
• F. Hoffmann-La Roche Ltd. (Genentech Inc.)
• Horizon Pharma plc.

key Findings of the Study:

• North America occupied an almost two-thirds share of the global PEGylated protein therapeutics market in 2017

• Cancer cells are expected to grow at the highest CAGR throughout the forecast period.

• Europe is expected to account for one-fifth of the worldwide market for PEGylated protein therapeutics by 2025.

• The Asia Pacific region is expected to grow at the highest rate during the analysis period, followed by LAMEA.

Browse More Information of Report @ https://www.alliedmarketresearch.com/press-release/PEGylated-proteins-market.html

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release PEGylated Protein Therapeutics Market Outlook 2025: Key Players Amgen, AstraZeneca, Biogen, Horizon Pharma here

News-ID: 1576249 • Views: 861

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for PEG

PEG-12 Dimethicone Market: Competitive Dynamics & Global Outlook 2025
LP INFORMATION recently released a research report on the PEG-12 Dimethicone market analysis, which studies the PEG-12 Dimethicone's industry coverage, current market competitive status, and market outlook and forecast by 2025. Global “PEG-12 Dimethicone Market 2020-2025” Research Report categorizes the global PEG-12 Dimethicone market by key players, product type, applications and regions,etc. The report also covers the latest industry data, key players analysis, market share, growth
PEG-10 Dimethicone Market: Competitive Dynamics & Global Outlook 2025
LP INFORMATION recently released a research report on the PEG-10 Dimethicone market analysis and elaborate the industry coverage, current market competitive status, and market outlook and forecast by 2025. Moreover, it categorizes the global PEG-10 Dimethiconemarket by key players, product type, applications and regions,etc. The main objective of this market research is to help the readers understand the structure of PEG-10 Dimethiconemarket, market definition, overview, industry opportunities and trends, investment
Application of PEG In Click Chemistry
Polyethylene glycol (PEG) is a biocompatible, synthetic, hydrophilic polyether compound that has many applications, mostly in the medical industry, but also in the chemical and industrial sectors. The synthesis of PEG is done by polymerizing ethylene oxide, the main ingredient in antifreeze, using a ring-opening technique, which allows for PEGs of a range of molecular weights and molecular weight distributions to be constructed. This range in weights is what makes
What Are PEG Linkers?
Hydrophilic poly(ethylene glycol) or PEG-linkers are particularly attractive as a linker for conjugation. Water solubility, lack of toxicity; low immunogenicity and well defined chain lengths and molecular weights are specific characteristics of PEG moieties relevant to pharmaceutical applications. Hydrophilic linkers The link between the antibody and the cytotoxic agent plays a critical role in development of antibody-drug conjugates. The nature of the linker can significantly affect the potency, selectivity, and the pharmacokinetics of
Biochempeg developed a series of PEG compounds used for Semaglutide
Type 2 diabetes is the most common form of diabetes. Semaglutide is an agonist of glucagon-like peptide-1 (GLP-1) receptor that is developed to treat type 2 diabetes. It reduces blood sugar via increasing the production of insulin. Biochempeg has developed and can supply some key intermediates of Semaglutide. Semaglutide(trade names: Rybelsus,Ozempic) is a medication for the treatment of type 2 diabetes. It was discovered in 2012, by a team of researchers
PEG-10 Lanolin Market Swot Analysis 2018 Industry Research 2023
Future Market Reports on Global PEG-10 Lanolin 2018 Research Report presents a professional and complete analysis of Global PEG-10 Lanolin Market on the current market situation. The Global PEG-10 Lanolin Market 2018 report includes PEG-10 Lanolin market Revenue, market Share, PEG-10 Lanolin industry volume, market Trends, Growth aspects. It analyses the important factors of the PEG-10 Lanolin market based on present industry situations, PEG-10 Lanolin market demands, business strategies utilized